Atara Biotherapeutics Is A Biotechnology Company Based In Thousand Oakscaliforniaspecializing In Allogeneic T Cell Immunotherapies For Cancerautoimmune Diseasesand Viral Associated Conditionsthe Company Is Recognized As The First Globally To Receive Regulatory Approval For An Allogeneic T Cell Immunotherapyutilizing A Proprietary Platform That Allows For Rapid Delivery Of Therapies Derived From Healthy Donors Atara S Innovative Approach Includes An Allogeneic Epstein Barr Virusebvt Cell Platformwhich Targets Ebv Driven Diseases Without The Need For Gene Editingthis Enables Scalable Manufacturingproducing Over 1 000 Doses From A Single Donorand Ensuring Therapies Are Available Within Daysthe Company S Product Pipeline Features Several Therapiesincluding Ebvalloa C For Ebvpost Transplant Lymphoproliferative Diseaseata3219 For B Cell Malignanciesand Ata188 For Multiple Sclerosisamong Othersatara Is Committed To Addressing High Unmet Medical Needs In Patientsparticularly Those With Cancer And Autoimmune Disorders
